Advertisement

Use of Theophylline and Sodium Cromoglycate in Pediatric Asthma

  • Akihiro Morikawa
Part of the Allergy Frontiers book series (ALLERGY, volume 5)

Theophylline and sodium cromoglycate are old drugs used in the treatment of asthma, but in some patients, they are still useful for maintenance therapy. Theophylline is not only a bronchodilator, but also has anti-inflammatory effects [1] due to multiple mechanisms including adenosine receptor antagonism and epigenetic influences over inflammatory gene expression both of which occur at lower concentrations (5–10 μm ml −1). In Japan, slow release theophylline is still used as a controller therapy except in infants with asthma [2]. Sodium cromoglycate produces only minimal side effects and is also used as a controller in persistent asthma, especially in infantile asthma.

Keywords

Allergy Clin Immunol Sodium Cromoglycate HDAC Activity Nedocromil Sodium Pediatric Asthma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barnes PJ, Pauwels RA. Theophylline in the management of asthma:time for reappraisal? Eur respire J. 1994;7:579–591CrossRefGoogle Scholar
  2. 2.
    Morikawa A, Nishima S. New Japanese pediatric guidelines for the treatment and management of bronchial asthma. Pediatr Int. 2007;49:1023–1031CrossRefPubMedGoogle Scholar
  3. 3.
    Finney MJB, Karlson JA, Persson CGA. Effects of bronchoconstriction and bronchodilation on a novel human small airway preparation. Br J Pharmacol. 1985;85:29–33PubMedGoogle Scholar
  4. 4.
    Wanner A. Effects of methylxanthines on airway mucociliary function. Am J Med. 1985;79:16–21CrossRefPubMedGoogle Scholar
  5. 5.
    Aubier M, De Troyer A, Sampson M, Macklem PT, Roussos C. Aminophylline improves diaphragmatic contractility. N Engl J Med. 1981;305:249–252PubMedCrossRefGoogle Scholar
  6. 6.
    Barnes PJ. Theophylline new perspectives for an old drug. Am J Respir Crit Care Med. 2003;167:813–818CrossRefPubMedGoogle Scholar
  7. 7.
    Pauwels R, van Revterghem D, van der Straeten M, Johanesson N, Persson CGA. The effect of theophylline and enprophylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol. 1985;76:583–590CrossRefPubMedGoogle Scholar
  8. 8.
    Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994;343:1006–1008CrossRefPubMedGoogle Scholar
  9. 9.
    Jaffar ZH, Sullivan P, Page C, Costello J. Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. Eur Respir J. 1996;9:456–462CrossRefPubMedGoogle Scholar
  10. 10.
    Kraft M, Torvik JA, Trudeau JB, Wenzel SE, Martin RJ. Theophylline: potential anti-inflammatory effects in nocturnal asthma. J Allergy Clin Immunol. 1996;97:1242–1246CrossRefPubMedGoogle Scholar
  11. 11.
    Rabe KF, Magnussen H, Dent G. Theophylline and selective PDE inhibitors as bronchodila-tors and smooth muscle relaxants. Eur Respir J. 1995;8:637–642PubMedGoogle Scholar
  12. 12.
    Poolson JB, Kazanowski JJ, Goldman AL, Szentivanyi A. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol. 1978;5:535–539CrossRefGoogle Scholar
  13. 13.
    Pauwels RA, Joos GF. Characterization of the adenosine receptors in the airways. Arch Int Pharmacodyn Ther. 1995;329:151–156PubMedGoogle Scholar
  14. 14.
    Bjorck T, Gustafsson LE, Dahlen SE. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis. 1992;145:1087–1091PubMedGoogle Scholar
  15. 15.
    Feoktistov I, Polosa R, Holgate ST, Biaggioni I. Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci. 1998;19:148–153CrossRefPubMedGoogle Scholar
  16. 16.
    Miura M, Belvisi MG, Stretton CD, Yacoub MH, Barnes PJ. Role of potassium channels in bronchodilator responses in human airways. Am Rev Respir Dis. 1992;146:132–136PubMedGoogle Scholar
  17. 17.
    Tomita K, Chikumi H, Tokuyasu H, Yajima H, Hitsuda Y, Matsumoto Y, Sasaki T. Functional assay of NF-kappaB translocation into nuclei by laser scanning cytometry: inhibitory effect by dexamethasone or theophylline. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:249–255CrossRefPubMedGoogle Scholar
  18. 18.
    Katz RM, Rachelefsky GS, Siegel S. The effectiveness of the short- and long-term use of crystallized theophylline in asthmatic children. J Pediatr. 1978;92(4):663–667CrossRefPubMedGoogle Scholar
  19. 19.
    Bierman CW, Pierson WE, Shapiro GG, Furukawa CT. Is a uniform round-the-clock theo-phylline blood level necessary for optimal asthma therapy in the adolescent patient? Am J Med. 1988;85(1B):17–20CrossRefPubMedGoogle Scholar
  20. 20.
    Pedersen S. Treatment of nocturnal asthma in children with a single dose of sustained-release theophylline taken after supper. Clin Allergy. 1985;15(1):79–85CrossRefPubMedGoogle Scholar
  21. 21.
    Nassif EG, Weinberger M, Thompson R, Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med. 1981;304:71–75PubMedCrossRefGoogle Scholar
  22. 22.
    Brenner M, Berkowitz R, Marshall N, Strunk RC. Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy. 1988;18(2):143–150CrossRefPubMedGoogle Scholar
  23. 23.
    Magnussen H, Reuss G, Jorres R. Methylxanthines inhibit exercise-induced bronchoconstriction at low serum theophylline concentration and in a dose-dependent fashion. J Allergy Clin Immunol. 1988;81(3):531–537CrossRefPubMedGoogle Scholar
  24. 24.
    Morikawa A, Nishima S. Japanese Pediatric Allergology. The Japanese Pediatric Guidelines (JPGL) 2005. Kyowa Kikaku, Tokyo, 2005Google Scholar
  25. 25.
    Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med. 1997;337:1412–1418CrossRefPubMedGoogle Scholar
  26. 26.
    Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, Leichtl S, Rathgeb F, Keller A, Steinijans VW. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur Respir J. 1997;10:2754–2760CrossRefPubMedGoogle Scholar
  27. 27.
    Lim S, Jatakanon A, Gordon D, Macdonald C, Chung KF, Barnes PJ. Comparison of high-dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice. Thorax 2000;55:837–841CrossRefPubMedGoogle Scholar
  28. 28.
    Rivington RN, Boulet LP, Cote J, Kreisman H, Small DI, Alexander M, Day A, Harsanyi Z, Darke AC. Efficacy of slow-release theophylline, inhaled salbutamol and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med. 1995;151:325–332PubMedGoogle Scholar
  29. 29.
    Urnov FD, Wolffe AP. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 2001;20:2991–3006CrossRefPubMedGoogle Scholar
  30. 30.
    Ito K, Caramori G, Lim S, Oates T, Chung KF, Barnes PJ, Adcock IM. Expression and activity of histone deacetylases (HDACs) in human asthmatic airways. Am J Respir Crit Care Med. 2002;166:392–396CrossRefPubMedGoogle Scholar
  31. 31.
    Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 2002;99:8921–8926CrossRefPubMedGoogle Scholar
  32. 32.
    Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits IL-1 β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000;20:6891–6903CrossRefPubMedGoogle Scholar
  33. 33.
    Altounyan, REt C. Inhibition of experimental asthma by new compound, disodium cromogly-cate, “Intal”. Acta Allergol (Kbh), 1968;51:677–693Google Scholar
  34. 34.
    Bissonette EY, Enciso JA, Befus AD. Inhibition of tumor necrosis factor-alpha (TNF-alpha) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol. 1995;105:78–84Google Scholar
  35. 35.
    Matsuo N, Shimoda T, Matsuse H, Obase Y, Asai S, Kohno S.Effects of sodium cromoglycate on cytokine production following antigen stmulation of a passively sensitized human lung model. Ann Allergy asthma Immunol. 2000;84:72–78PubMedGoogle Scholar
  36. 36.
    Holgate ST. Clinical evaluation of nedocromil sodium in asthma. Eur J Respir Dis Suppl. 1986;147:149–159PubMedGoogle Scholar
  37. 37.
    Matsuse H, Shimoda T, Matsuo N, Obase Y, Fukushima C, Asai S, Kohno S. Sodium cromo-glycate inhibits antigen-induced cytokine production by peripheral blood mononuclear cells from atopic asthmatics in vitro. Ann Allergy Asthma immunol. 1999;83:511–515PubMedGoogle Scholar
  38. 38.
    Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics sixth ed. Macmillan Inc., N Y, 1980, 621Google Scholar
  39. 39.
    Shatz M, Zeiger KS, Berstein IL, Johson CL. Therapy with cromolyn sodium. Ann Intern Med. 1978;89:228–233Google Scholar
  40. 40.
    Tasche MJ, Uijen JH, Bernsen RM, de Jongste JC, van den Wouden JC. Inhaled disodium cromoglycate(DSCG) as maintenance therapy in children with asthma:a systematic review. Thorax 2000;55:913–920CrossRefPubMedGoogle Scholar
  41. 41.
    Hambleton G, Weinberger M, taylor J, Cavanaugh M, Ginchansky E, Godfrey S, Tooley M, Bell T, Greenberg S. Comparison of cromoglycate (cromolyn) and theophylline in controlling symptomed of chronic asthma. A collaborative study. Lancet 1977;19:381–385Google Scholar
  42. 42.
    Kelly K, Spooner CH, Rowe BH. Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics. Cochrane Database Syst Rev. 2000;4:CD002731PubMedGoogle Scholar
  43. 43.
    Spooner CH, Spooner GR, Rowe BH. Mast-cell stabilizing agents to prevent exercise-induced bronchoconstriction Cochrane Database Syst Rev. 2003;4:CD002307PubMedGoogle Scholar
  44. 44.
    Furusho k, Nishikawa K, Sasaki S, Akasaka T, Arita M, Edwards A. The combination of nebulized sodium cromoglycate and salbutamol in the treatment of moderate-to-sevre asthma in children. Pediatric Allergy Immunol. 2002;13:209–216CrossRefGoogle Scholar
  45. 45.
    Guevara JP, Duchame FM, Keren R, Nihtianova S, Zorc J. Inhaled corticosteroids versus sodium cromoglycate in children and adult asthma. Cochrane Database Syst Rev. 2006;19(2):CD003558Google Scholar
  46. 46.
    Busse WW, Lemanske RF, Jr. Asthma. N. Eng J Med. 2001;344:350–362CrossRefGoogle Scholar
  47. 47.
    Global Strategy for Asthma Management and Prevention 2006. National Institute of Health, National Heart, Lung, and Blood InstituteGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.Kitakanto Allergy Institute, Kibounoie HospitalMidoriJapan

Personalised recommendations